Accepted for Publication: June 19, 2022.
Published: August 4, 2022. doi:10.1001/jamanetworkopen.2022.25339
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Peña PA et al. JAMA Network Open.
Corresponding Author: Anupam B. Jena, MD, PhD, Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115 (firstname.lastname@example.org).
Author Contributions: Dr Peña had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: All authors.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: All authors.
Conflict of Interest Disclosures: Dr Jena reported receiving consulting fees from Bioverativ, Merck/Sharp/Dohme, Janssen, Edwards Life Sciences, Novartis, Amgen, Eisai, Otsuka Pharmaceuticals, Vertex Pharmaceuticals, Celgene, Sanofi Aventis, Precision Health Economics, and Analysis Group outside the submitted work; Dr Jena also reported receiving income from hosting the podcast Freakonomics, M.D., and from book rights to Doubleday Books outside the submitted work. No other disclosures were reported.